Partnering for Formulation Development

Formulation Models

Predictive Formulation: Can Modeling Reduce Empirical Development?

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

Spray-Dried Dispersions vs. Nanocrystals: Which Is Better for Solubility Enhancement?

Nice Insight

Pathfinder

Micronization vs. Nanomilling vs. Amorphous Solid Dispersions: Which Is Better for Poorly Soluble Drugs?

Nice Insight

Child Formulation

The Pediatric Formulation Gap

Pharma's Almanac

TPDs

Low Dose, High Impact: Microdosing, Content Uniformity, and Precision Control in TPDs

David O’Connell

PCI Pharma Services

Partner Selection

How are organizations balancing cost with regulatory, supply chain, and reputational risk when selecting partners or sites?

Pharma's Almanac

ADC Formulation

Controlling Complexity in ADC Formulation Development

Eunbi Iris Cho, Ph.D.

Samsung Biologics

Combination Products

Collaboration is Key to Successful Injectable Drug–Device Combination Product Development

Cynthia A. Challener, Ph.D.

Pharma's Almanac

High-Concentration

High-Concentration Biologics Are Redefining Subcutaneous Delivery

Pharma's Almanac

LAI Formulation

The Formulation Science Behind Extended Drug Release

Pharma's Almanac